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Coloprep is a bowel preparatory solution given before endoscopic procedures to get a unob-
scured internal vision. It has among its constituents’ sodium sulphate, potassium sulphate
and  magnesium sulphate which produce an osmotic effect in the bowel. However, the use
of  such agents in hyponatremic and patients predisposed to seizures can have adverse
ramiﬁcations. The current case outlines manifestation of absence seizure in a 52-year-old
male  patient who was administered Coloprep for colonoscopy. There was absence of other
predisposing factors and the symptoms were ameliorated using timely identiﬁcation and
rectiﬁcation of the underlying derangements.
© 2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. This
is  an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Convulsão  de  ausência  com  o  uso  de  Coloprep  em  colonoscopia
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Coloprep é uma soluc¸ão preparatória intestinal administrada antes de procedimentos
endoscópicos, com o objetivo de se ter uma visão interna não obscurecida. Entre os consti-
tuintes de Coloprep, observa-se sulfato de sódio, sulfato de potássio e sulfato de magnésio,
que provocam efeito osmótico no intestino. Mas o uso de tais agentes em pacientes hipona-
trêmicos e com predisposic¸ão para convulsões pode ter ramiﬁcac¸ões adversas. O caso em
tela  delineia uma manifestac¸ão de convulsão de ausência em paciente do gênero masculino
com 52 anos e que recebeu Coloprep para colonoscopia. Não havia outros fatores predispo-nentes e os sintomas melhoraram grac¸as à oportuna identiﬁcac¸ão e correc¸ão dos transtornos
subjacentes.©  2016 Sociedade Bras
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Introduction
Absence seizure also known as petit mal  seizure belongs
to the group of non-convulsive status epilepticus and is
characterized in EEG by bilateral synchronized spikes with
wave complex bursts. Its hallmark features include sudden-
onset impairment of consciousness, blank stare, upward gaze,
frozen movements and abrupt speech draught.1 Unlike other
seizures, it does not have post-dromal disorientation and
lethargy. Although hyponatremia is a rare causative factor of
absence seizure, it is not unheard of and can be precipitated
due to excess sodium loss or as a result of polydipsia. The ther-
apy mainly involves administration of normal saline solution
to correct the imbalance and since initially the causation is
unknown, a benzodiazepine agent can be used to subdue the
episodes before moving towards further work-up on the issue.
ColoprepTM is a bowel preparatory solution used prior to
endoscopic and surgical procedures which necessitate a clean
bowel. It is composed of sodium sulphate 17.5 g, potassium
sulphate 1.6 g and magnesium sulphate 3.13 g/177 mL  and
produces watery bowel stools through its osmotic effect. The
modality, although extremely common is not without risks
and has serious potential to induce electrolyte abnormalities
which may further propagate into seizures.
Case  history
A 52-year-old male patient presented to the internal medicine
department of a super-speciality hospital in Kerala with com-
plaints of anorexia, tiredness and constipation since 3 weeks.
The patient was conscious and alert with the vitals nor-
mal  except for mild elevations in blood pressure (140/85 mm
Hg) and temperature (99◦F). The patient had been on anti-
hypertensive therapy with Lisinopril 5 mg  since 3 years and
prior history of interstitial lung disease as well as gall stones.
The patient expressed concerns over loss of 5 kg in the past
2 weeks and after examination, the physician ordered liver
function test (LFT), blood routine examination, differential
leukocyte count and serum electrolyte concentrations. Blood
and electrolyte investigations divulged elevations in total
leukocyte (15 000 cells/mm3), differential lymphocyte (39%)
and serum potassium (5.4 mmol/L) The LFT results revealed
elevations in ALP (223 IU/L) and gamma-glutamyl transferase
(149 U/L) which suggested a possibility of cholestasis and the
patient was admitted for further evaluation. Therapy was
started with paracetamol, multivitamin & mineral supple-
ment and calcium gluconate. The physician after meticulous
contemplation, decided to perform an oesophago-gastro duo-
denoscopy (OGD) coupled with magnetic resonance cholan-
giopancreatography (MRCP) and colonoscopy up to ileum to
rule out possibilities of malignancies and explore for possible
gall stone obstructions. The patient cleared the cardiac, pul-
monology and neurology departments risk evaluations and
got a green ﬂag for endoscopic examination. As preparation
for the procedure, patient was advised to intake 2 bottles of
ColoprepTM composed of sodium sulphate 17.5 g, potassium
sulphate 1.6 g and magnesium sulphate 3.13 g/177 mL.  The
advice was to intake 1st bottle along with 1 L of water on the 1 6;3  6(2):119–121
night before and the next bottle, on the morning of the pro-
cedure day. However, during the period of intake of the ﬁrst
bottles, the patient contracted brief episodes of loss of con-
sciousness and orientation characterized by unresponsive-
ness despite his eyes staring wide open. There were also symp-
toms of bradykinesia upon regaining consciousness, decrease
in speech and confusion. The patient was immediately shifted
to the intensive care unit and was ordered for serum elec-
trolyte levels and electroencephalogram. The EEG showed
revealed bilateral spike and slow wave  complexes whereas,
the serum sodium level was found to be on the lower side with
value of 128 mmol/L. The patient was stable after shifting to
ICU where he was administered 1500 mL  normal saline infu-
sion and 5 mg  diazepam. The causality assessment was done
using Naranjo algorithm with a resulting score of 5 indicating
towards a probable association between the drug and reaction.
After stabilization of the patient, colonoscopy was performed
without further colorectal evacuation and MRCP revealed gall
stones for which further therapy was initiated.
Discussion
The signs of reaction indicated towards symptoms of absence
seizure and was further cemented by the EEG reading. The
patient was evaluated to have no other risk factors or recur-
rence of seizure episodes indicating a strong link between
the drug and reaction. Although very few case reports have
emerged regarding bowel cleansing medications induced
seizure episodes, they all concur on the mechanism through
which seizures are induced and the current case is not
dissimilar.2,3 The serum electrolyte disturbance with potas-
sium was evident on the initial day which was rectiﬁed
using calcium gluconate; however, the sodium levels which
were normal on the ﬁrst day was found to have declined
to a hyponatremic level in the post-seizure phase. How-
ever, there was no electrolyte monitoring done on the day
of administration of ColoprepTM which obscures the fact
whether hyponatremia was already present and potentiated
or whether there was an exclusive induction. Electrolyte dis-
turbances has been clearly stated as a contraindication for
the use of combination of sodium sulphate, potassium sul-
phate and magnesium sulphate in lights of its potential for
precipitating seizure episodes.4,5
Although international league against epilepsy (ILAE) com-
mission on epidemiology recognized lack comprehensive data
on the causal effect relationships between metabolic derange-
ments and seizure, it has laid down arbitrary limits for
disturbances such as hyponatremia and risk of seizure.6
Serum sodium level below 125 mmol/L is regarded as a
potential risk factor for development of seizure in patients,
especially those with underlying seizure risk. When there
is hyponatremia, a cerebral protective mechanism sets into
motion through active extrusion of electrolytes and organic
osmolytes. However, when this protective mechanism is over-
whelmed due to other predisposing factors such as hypoxia,
it can culminate in cerebral edema which manifests as refrac-
tory seizures.7
The effective management strategy in such cases involves
immediate shifting of the patient to ICU, where a more
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ndividualized monitoring can be provided round the clock.
nitially, a differential diagnosis should be considered and the
reatment can be provided with an aim to establish patient sta-
ility. Different reasons should be considered such as chance
f hypotensive syncope and other reasons for sodium deple-
ion in the patient. Causality assessment can be utilized as an
ntegral part of the root cause analysis to provide a more  com-
rehensive interpretation. Normal saline infusion, either 1000
o 1500 mL  will usually be sufﬁcient to replenish the electrolyte
bnormalities in these patients and prevent further deterio-
ation of the patient status. The patient can be immediately
iven a benzodiazepine agent such as diazepam at low dose
o subdue the seizure episode and prevent further adversities.
Each patient who  is being given such bowel cleansing solu-
ions must be carefully analyzed for contraindications such
s electrolyte abnormalities and other potential predisposing
actors for seizure before initiation of the regimen.onﬂicts  of  interest
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